TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor ...

New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD

New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of ...
IEEE

An Efficient Deep Transfer Learning Network for Characterization of Stroke Patients’ Motor Execution from Multi-Channel EEG-Recordings

Abstract: Recent advances in stroke rehabilitation technology have been focused on developing Intelligent Rehabilitation Robots (IRR) that can effectively engage post-stroke patients (PSP) in ...